|
|
|
|
NLARx News
NLARx Calls on Congress to Include Pharmaceutical Reforms in Its Healthcare Initiative More
NLARx Joins Coalition of Groups Endorsing Biogenerics Legislation More
An Interview with NLARx Member David Catania More
|
In the States
VERMONT: Comprehensive Law on Datamining, Academic Detailing, Deceptive Marketing Upheld by Courts More Vermont House Passes Marketing Disclosure Bill More
Prescription Project Testimony Supporting Legislation to Regulate Drug Marketing More
VT Association for Mental Health Testimony Supporting Legislation to Regulate Drug Marketing More
MAINE: Committee Supports Sen. Schneider's Bill Regulating Marketing to Minors More
OREGON: Gift Disclosure Law Still Pending More
CALIFORNIA: Prescriber Education Clears Committee in California More
TEXAS: Several Pharmaceutical Bills Make Progress in Texas More
KANSAS: Legislature Sets Up Program to Redistribute Unused Meds More
NEW YORK: Prescription Drug Relief for Western New Yorkers More
NEW JERSEY: Agreement Forces Disclosure of Conflicts of Interest in Clinical Trials More
NEW YORK: Medicaid Fraud Investigations Recover $263.5 Million, Net Convictions
More
COLORADO: Bill Requiring Insurance to Cover Chemo Medicines Defeated More
FLORIDA: Florida House Passes Measure To Curb Medicaid, Medicare Fraud More
CONNECTICUT: No More Free Lunches For Doctors? More
|
Outrage of the Week
Merck Published Fake Medical Journal to Promote Its Products More
|
Fraud and Abuse
Forest Labs Reserves $170 Million to Face Marketing Fraud Investigation | >>more |
Prices and Access to Healthcare
US Census Bureau Says Insurance Coverage Deteriorating Rapidly With Job Losses More
Drug Deals Tie Prices to How Well Patients Do More
Signa and Merck Sign 'Pay for Performance' Deal for Prescription Drugs More
As Pills Treat Cancer, Insurance Lags Behind More
Prices On Oral Chemo Drugs Up 33% or Higher More
Shift to Pills Can Leave Cancer Patients On the Hook More
Avoid Sticker-Shock at the Pharmacy Counter with Best Drugs for Less More
Poll Highlights Public's Views on Health Costs, EHRs, Comparative Effectiveness Research More |
Patents and Generics
Fight Looms Over Competing Biogeneric Bills More
$1331 Spent Every Second on Brand Name Biologics More
Europe Jumps Ahead on Cheaper Biotech Drugs More
Abbott Sues J&J Over New Humira Rival More
Will Compulsory Licensing Hit Roche, Glaxo? More
|
Conflicts of Interest
Forthcoming Proposed Rule on Conflicts To Include New Requirements, NIH Chief Says More
Institutes of Medicine Calls on Physicians To Reject Financial Arrangements With Drugmakers More
Controlling Conflict of Interest - Proposals from the Institute of Medicine More
PhRMA Industry Group Revises Principles To Improve Clinical Drug Trial Transparency
More
Pharma Support of Medical Societies Raises Conflict-of-Interest Concerns More
|
Advertising and Marketing
Prescription Project Testimony before VT House Committee on Healthcare More
Consumers, Doctors Want Drug Ads to Contain More Facts More
Vermont District Court Upholds Data-Mining Law More
Taking a Page, and a Pen, From Makers of Medicines More
|
Pharma Watch
U.S. Drug Sales Projected to Decline This Year More
U.S. Pharma Market Could Contract for First Time In More Than 50 Years More
Big Pharma Swallows Billions in Biotechs More
Agreements Between Some Drugmakers, Insurers Link Prescription Drug Effectiveness to Price
More
Glaxo, Roche Start to Map Swine-Flu Game Plans More
Glaxo, Roche Combat Antiviral Hoarding More
SEC Probes Schering Trades on Eve of Merck Deal More
Are Three More Mega-Deals in Pharma's Cards? More
Lilly Announces It Has No Plans to Buy Amylin More
Pfizer's Lipitor Sales Fall, Biotech Chief Exits More
More Sales Rep Jobs Cut, This Time at Amylin More
Abbott Shareholders Don't Want Say On Executive Pay More
Biovail Buys U.S. Rights to Wellbutrin From Glaxo for $510 Million More
A Break for Pharma? Senator Chuck Grassley May Leave Finance Panel More
|
PBM Watch
Change to Win Testimony in Support of Maine PBM Legislation More
Wal-Mart Tries to Step on Prescription Benefit Managers' Turf More
Wal-Mart Expands Discount Drug Program to Businesses More
Express Scripts Merger Comes as Wal-Mart Threat Rises More
Federal Trade Commission asked to investigate Express Scripts acquisition More
Ask Your Pharmacist: Where Can I Get Good Information on M&As in the Drugstore Industry? More
CVS Caremark Lifts Outlook on Expected PBM Growth More
CVS Program Steers Customers of the PBM Business to Its Pharmacies More
|
Medicare
Medicare Says It Won't Help Seniors Overcharged by Prescription Drug Program More
Social Security Benefits Will Have 'Major Implications' on Medicare Parts B, D More
Proposed Decision Denies Medicare Coverage for Genetic Tests To Determine Best Warfarin Dosage More
Medicare Cancer Patients Win Battle Over Off-Label Coverage More
One Woman's Victory Indicates Successful Implementation of Off-Label Coverage Standard for Cancer Drugs More
|
Medicaid
WellCare to Pay $80 Million to Avoid Medicaid Fraud Charges More
Medicare Fraud Linked to Inhalation Drugs Prevalent in South Florida More
|
Safety and Clinical Trials
Federal Panel Hears Public Concerns About Comparative Effectiveness Research More
Bill Would Give FDA Resources for Inspections More
FDA Requires Stronger OTC Pain Medicine Labels More
FDA Approves Emergency Drug Use to Combat Flu Outbreak More
Drug Counterfeiters See Opportunity in Flu More
Botox Gets Stuck With Black-Box Warning More
Cephalon Says a Treanda Patient Dies of Skin Rash More
Medicare Deals Setback to Genetic Testing for Warfarin Use More
Mental Health Prescriptions Increased by 50% Among Children From 1996-2006, Study Finds More
Post-Preemption Ruling, Drug Suits Get Moving More
Review Board That Approved Fake Study Calls it Quits More |
Trade and Importation
Public Health Officials Applaud Bill to Open Trade Committees More
Prescription Drug Reimportation and the Economic Downturn More
|
Executive Branch Appointments
Senate Confirms Kansas Governor Sebelius as HHS Secretary More
Senate Panel to Hold Confirmation Hearing On Nomination of New FDA Commissioner More
|
Electronic Records
EMR Adoption Higher in States with Fewer Privacy Rules More
Veterans Administration Provides Free Software for Hospital EHR Systems More
|
Op-Eds
Are Increased Foreign Inspections of Plants the Answer to Better Risk Management? More
Comparative Effectiveness Could Have 'Profound, Positive Effect on How
Medical Decisions Are Made' More
Off-Label Uses of Drugs Should Be Approved for Very Ill Patients More
| |
|
|
|
|
|
